ABSTRACT
INTRODUCTION
Ehrlichia canis, the etiological agent of canine monocytic ehrlichiosis (CME), is a bacteria distributed worldwide that may cause lethal disease in dogs (AGUIAR et al., 2015) . The pathogenesis of the disease involves an incubation period of 8 to 20 days, followed by an acute, subclinical and sometimes chronic phase (HARRUS & WNER, 2011) . Normally, during the acute phase, infected dogs recover spontaneously. However, when they enter the subclinical stage, the dogs remain infected for longer periods. At this stage, dogs do not eliminate the agent from the body, and they develop the chronic phase of the disease, characterised by bone marrow suppression and bleeding, followed by death (WANER & HARRUS, 2013) .
Because the clinical signs associated with the disease are nonspecific, clinical diagnosis is difficult. Therefore, a laboratory diagnosis of infections caused by E. canis morulae is performed using the visualisation of mononuclear cells, the detection of antibodies using serological techniques and molecular analysis using PCR (TANIKAWA et al., 2013) .
The introduction of molecular techniques for the detection of E. canis has allowed for the rapid, sensitive and specific diagnosis of acute and chronic phases of the disease. Various PCR techniques can be used, such as nested PCR (OLIVEIRA et al., 2009) , RFLP-PCR (restriction fragment length polymorphism) and real-time PCR (BANETH et al., 2009) . Several target genes, including p28, p30, dsb, and VirB9, and PCR for the 16S rRNA gene and p30 are the most commonly used targets (HARRUS & WANER, 2011) . Different biological sites can also be used (WANER & HARRUS, 2013) . Animal health and CME is of global importance. The objective of this study was to compare the presence of E. canis DNA in the blood and bone marrow of dogs, as well as to determine the occurrence of E. canis in Várzea Grande, Mato Grosso.
MATERIALS AND METHODS

Animals and study area
Dogs in this study were obtained from a cross-sectional study for canine visceral leishmaniasis in the municipality of Várzea Grande, Mato Grosso, the neighbourhoods of São Matheus, Jardim Eldorado and Parque Sabia, coordinates 15º57'55" S 54º58'06" W. The survey was conducted by home visits, considering one residence for every five, totalling 521 dogs. The bone marrow was obtained from approximately 10% of the population studied. Dogs of all ages, both sexes and different breeds were included in this study with prior permission of the owner. The dogs were clinically evaluated for the presence of clinical signs of infection with E. canis, such as apathy, anorexia, weight loss, lymphadenopathy, hepatomegaly, splenomegaly and ophthalmopathy and the clinical and epidemiological characteristics of the registered disease.
With the consent of the owners, the dogs were mechanically restrained and underwent sedation with ketamine hydrochloride (10mg kg ). Approximately 5ml blood was collected by cephalic or jugular puncture into tubes containing anticoagulant for the recovery of the buffy coat by centrifugation. Bone marrow samples (0.5mL) were obtained via aspiration of the sternum manubrium and were stored in microtubes containing anticoagulant after prior asepsis and local anaesthesia. The biological specimens were stored at -20° until use.
DNA extraction and PCR
Extraction of DNA samples was performed using phenol/chloroform/isoamyl alcohol according to GOMES et al. (2007) . E. canis DNA detection was performed using nested PCR. The primers used for the first amplification step were as follows: ECC (5'-AGAACGAACGCTGGCGGCAAGC-3') and ECB (5'-3'CGTATTACCGCGGCTGCTGGCA-3'). Primers for the second stage were ECAN (5'-CAATTATTTATAGCCTCTGGCTATAGGA-3') and HE3 (5'-TATAGGTACCGTCATTATCTTCCCTAT-3'). These primers amplify fragments of 458 and 398 bp, respectively, of the 16S rRNA gene (MURPHY et al., 1998) . Positive control was (dog 3577) an animal positive for E. canis, and a negative control (DNA-free reaction) was also included in all PCR experiments. Amplified products were fractionated by agarose gel electrophoresis, stained with 1.5% gel Red and visualised transilluminator (UV-300 nm). To verify that no Leishmania DNA was amplified, the primers used were tested using the DNA reference strain L. (L.) infantum (MHOM/BR/1974/PP75), and no nonspecific amplification was observed. To confirm the species, eight (10%) samples were sequenced at the Sanger Sequencing facility (Applied Biosystems ® Genetic Analysis, Foster City, CA) according to the manufacturer's recommendations.
Statistical analysis
Data were transferred to a database and analysed with the software Epi Info 3.3.2 (CDC, Atlanta, GA, USA) using Fisher's exact or chi-square tests to assess the association between independent variables, the presence of E. canis DNA positive results, the differences in the frequency for each clinical sample and the comparison of the clinical status of dogs at the 5% significance level.
RESULTS
Of the 80 dogs surveyed, 61 (76.3%) had E. canis DNA in one of the surveyed samples. No association was observed between gender, age, race, origin of dogs, free access to the street, or the presence of ticks (Table 1 ). In the analysis of biological samples, the buffy coat were positive in 42 (52.5%) and the bone marrow was positive in 33 (41.3%) of 80 dogs. Of the positive dogs, 14 (17.5%) showed DNA amplification of E. canis in both samples. The PCR products of eight dogs (10%) were sequenced, resulting in DNA sequences 100% identical to the sequences of E. canis in GenBank (accession numbers KP844663.1, KJ995842.1, KF972452.1, and JX118827.1).
Of all the dogs, 29 (36.3%) were asymptomatic, and 51 (63.8%) showed some clinical signs consistent with infection by E. canis, of which, 21 (72.4%) and 40 (78.4%), respectively, were positive by PCR, with no statistically significant difference (P=0.73). The primary clinical signs observed were apathy, weight loss, lymphadenopathy, splenomegaly, hepatomegaly and ophthalmopathies.
For clinical the presence or absence of clinical signs, there was no significant association between the positivity of the biological samples, buffy coat and bone marrow (Table 2 ). There was no significant association between the two types of biological samples within the asymptomatic dog group (P=0.24) and symptomatic group (P=0.49).
DISCUSSION
The high incidence of infection with E. canis found in this study is consistent with data obtained in different regions of Brazil (DAGNONE et al., 2009; TANIKAWA et al., 2013) and Mato Grosso (MELO et al., 2011) based on serological analysis. In this study, nested PCR of buffy coat and bone marrow samples showed an occurrence of infection in 76% of dogs. This finding differs from that of WITTER et al. (2013) , who analysed buffy coat samples and observed E. canis infection in 23.3% of dogs. The high occurrence can be related using two sites where bacteraemia is observed during different stages of the disease (MILONAKIS et al., 2003) .
Direct exposure to the vector tick, R. sanguineus (CARLOS et al., 2011) and age (COSTA JUNIOR et al., 2007) were considered risk factors for infection with E. canis in other regions; however, these factors were not associated with infection in the dogs surveyed, as described by SILVA et al. (2012) .
In epidemiological analyses, the blood sample is easily obtainable and provides good results (SILVA et al., 2012; SANTOS et al., 2013) . However, the detection of the agent can decrease at this site with the progression of infection or the treatment of bacteraemia compared to other sites (HARRUS et al., 2004; BANETH et al., 2009) The absence of apparent clinical signs and the long duration of the subclinical stage may hinder the detection of infection (HARRUS & WANER, 2011; WANER & HARRUS, 2013) , likely represented in this study by the asymptomatic group. HARRUS et al. (1998) observed the increased detection of E. canis in spleen samples in the subclinical stage, and in blood and bone marrow in the acute phase, whereas the number of positive animals detected by PCR using blood and spleen samples was similar (HARRUS et al., 2004) . However, spleen samples are not routinely Table 2 -DNA detection of E. canis using nested PCR in the buffy coat and bone marrow compared to clinical signs observed in dogs in Várzea Grande, Mato Grosso. MYLONAKIS et al. (2003) reported the occurrence of E. canis sequestration in the spleen during the subclinical stage and chronic disease as well as in the bone marrow during the chronic phase.
CONCLUSION
Infection with E. canis is highly prevalent in dogs in the city of Várzea Grande, Mato Grosso, and bone marrow is a good site for the molecular diagnosis of canine ehrlichiosis, particularly when infection is suspected despite of negative blood sample.
